>=99% Purity | Third-Party Verified
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research has focused on its effects on adipose tissue reduction, metabolic rate modulation, and appetite signaling pathways. Phase 2 clinical trials have demonstrated significant effects on body weight and metabolic markers.